SCHEMBL5870372

SCHEMBL5870372

CCCc1[nH]cnc1C(=O)Cl

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.44
HSD17B10 Q99714 1/20 0.44
LMNA P02545 1/20 0.41
KDM4E B2RXH2 4/20 0.39
SMN1; SMN2 Q16637 2/20 0.35
GAA P10253 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
MAPT P10636 2/20 0.34
ALDH1A1 P00352 4/20 0.33
GABRR1 P24046 1/20 0.33
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
HPGD P15428 1/20 0.32
HCAR2 Q8TDS4 1/20 0.32
MAPK1 P28482 1/20 0.31
XDH P47989 1/20 0.31
PDK2 Q15119 1/20 0.31
PDK4 Q16654 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6499135 0.81 CYP2C19 (0.44) CYP2C19HSD17B10LMNAKDM4ESMN1; SMN2
Hydrochloric Acid SCHEMBL5869997 0.81 CYP2C19 (0.62) CYP2C19HSD17B10LMNAKDM4ESMN1; SMN2
SCHEMBL5870375 0.79 SMN1; SMN2 (0.42) CYP2C19HSD17B10LMNAKDM4ESMN1; SMN2
SCHEMBL5870445 0.77 KDM4E (0.58) HSD17B10LMNAKDM4ESMN1; SMN2GAA
SCHEMBL2101530 0.75 LMNA (0.45) CYP2C19HSD17B10LMNAKDM4ESMN1; SMN2
SCHEMBL7325537 0.75 CYP2C19 (0.39) CYP2C19HSD17B10LMNAKDM4ESMN1; SMN2
SCHEMBL14692540 0.74 CYP2C19 (0.57) CYP2C19HSD17B10LMNAKDM4EALDH1A1
SCHEMBL5870451 0.74 HPGD (0.41) CYP2C19HSD17B10KDM4ESMN1; SMN2GAA
SCHEMBL5870140 0.72 KMT2A (0.54) HSD17B10KDM4ESMN1; SMN2GAAL3MBTL1
Hydrochloric Acid SCHEMBL11004255 0.71 GABRR1 (0.44) CYP2C19HSD17B10LMNAKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7078528-B2 Biimidazole diamide anion binding agents EAST CAROLINA UNIVERSITY (US) 2006-07-18 US disclosed
US-20050004370-A1 Biimidazole diamide anion binding agents EAST CAROLINA UNIVERSITY 2005-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050004370-A1 Biimidazole diamide anion binding agents ABCG2, BRI3BP, SLCO1B3 CYP2C19 2427/4885HSD17B10 2912/4885LMNA 4654/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.